HUTCHMED (00013): Executive Director and Chief Financial Officer Chi-chung Cheng appointed as acting Chief Executive Officer.
Huahuang Medicine (00013) issued an announcement that the Board of Directors was informed that the executive director of the company, Mr. Su Weiguo, will temporarily suspend his duties due to health reasons...
HUTCHMED (00013) announced that the Board of Directors has been informed that the Company's Executive Director, Mr. Su Weiguo, will temporarily suspend his duties as Chief Executive Officer for health reasons.
In light of this, the Board of Directors has appointed Mr. Zhou Zefeng, the Company's Executive Director and Chief Financial Officer, to serve as Acting Chief Executive Officer with immediate effect.
In addition to his role as Chief Financial Officer, Mr. Zhou will also be responsible for overseeing the Company's daily operations and management during the transition period to ensure the continuity of the Company's leadership and decision-making.
Related Articles

TAIZHOU WATER (01542) announced its interim results, with the attributable loss to the owners of the parent company approximately 19.875 million yuan, a year-on-year decrease of 45.21%.
.png)
CONGYU INTE AGR (00875) announced its interim results, with a net profit attributable to shareholders of HK$1.262 million, a decrease of 86.4% year-on-year.

KIDZTECH (06918) released its mid-year performance, with a net loss attributable to shareholders of 15.036 million yuan, a decrease of 14.49% year-on-year.
TAIZHOU WATER (01542) announced its interim results, with the attributable loss to the owners of the parent company approximately 19.875 million yuan, a year-on-year decrease of 45.21%.

CONGYU INTE AGR (00875) announced its interim results, with a net profit attributable to shareholders of HK$1.262 million, a decrease of 86.4% year-on-year.
.png)
KIDZTECH (06918) released its mid-year performance, with a net loss attributable to shareholders of 15.036 million yuan, a decrease of 14.49% year-on-year.

RECOMMEND

EU Proposes Legislation to Enact Transatlantic Trade Framework by Eliminating Select U.S. Tariffs and Reducing Auto Duties to 15%
29/08/2025

Six Months In, WuXi Juno’s Revenue Just Exceeds RMB 100 Million as Commercialization of High-Priced Cancer Therapy Stalls
29/08/2025

Offshore Renminbi Briefly Exceeds 7.12 for First Time in Nearly Ten Months, Future Trajectory Under Scrutiny
29/08/2025